Retina Practice Solutions

Discover how we make your retina specialty practice more manageable.

A drawing of a doctor scanning a prescription card

People and Solutions that Clear the Path so You Can Care for Your Patients

As an independent community retina practice, you can rely on the people at McKesson. While you focus on patient care, we clear the path with solutions that make practice management more manageable. From smarter comprehensive drug management to insightful advisors and tools, we’re ready to help your practice discover the McKesson difference.

Today, building and growing a retina practice takes more than medical expertise. While significant pressure and emphasis are placed on clinical knowledge, we see that retina specialists are seeking ways to successfully manage the business side of their practice (from new regulations to changes in drug pricing) which is critical for maintaining independence and future growth.

We clear the path so you can focus on patient care

Discover how McKesson addresses your retina specialty practice’s business challenges outside of the operating and examination rooms so you can give better care for your patients. Our personalized, all-in approach combined with proven know-how, insights and a portfolio of comprehensive solutions helps ensure your practice’s efficiency, productivity, and profitability stays on track for long-term growth.

The health of your retina practice goes beyond just distribution, and so does our support. We’ve tailored solutions, like Lynx® and the Onmark® GPO, for retina specialists to help you find greater efficiency and financial success. We develop actionable solutions to ensure your patients always have the choice of quality care in their community.

The McKesson Difference

We’re all in to help you stay strong and independent.
We take the time to get to know your practice, and tailor our advice and efforts to meet your evolving needs.

Your patients trust you to give the personal attention they deserve, the quality of care they expect, and the hope they need. As an independent specialty care provider, you play a critical role in driving better patient outcomes close to home.

And you matter to McKesson. We care about your practice and your success, the way you care about your patients and their health. Making it easier to build a name in your community, spend more time with patients, and run your business the way you want to is at the center of what we do. When you choose McKesson, you get the dedication and support you deserve.

Our solutions deliver insights and a positive impact to your retina practice. You choose what you want, when you need it.

With McKesson, you’ll see a positive shift in your patient care, productivity and profits. Here’s how we do it:

A delivery truck parked in front of a building

Smarter, comprehensive drug management

We start with the most comprehensive specialty drug management solution portfolio available in the market. Count on getting the right medicines at the right time – reliably, safely and efficiently – with our state-of-the art distribution systems. Gain purchasing power and savings by uniting with your peers under our group purchasing organization for retina practices. Manage your retina drug inventory and minimize lost doses. And capture more specialty drug reimbursements. Save money by maximizing billing and coding.



A dollar sign with rotating arrows encircling it.

Business and clinical advisors

Our experienced practice consultants provide guidance and tailor a plan just for your practice. See what policy and regulatory changes are in your future. Get support to adapt to Centers for Medicare & Medicaid Services (CMS) payment models and avoid penalties. And, access clinical education and resources and personalized clinical consulting when you need it.

Ask us how we can help your retina practice today!

A cartoon person sits at a desk

Biosimilar Master Class

Dr. Robert Rifkin and a team of expert clinical specialists and business advisors help you understand biosimilars from the U.S. Food and Drug Administration (FDA) perspective. While similar to biologic reference products, biosimilars have unique operational, clinical, and financial decision points critical to successfully implementing these therapies in your practice.